APA (7th ed.) Citation

Brown, M. L., Motsch, J., Kaye, K. S., File, T. M., Boucher, H. W., Vendetti, N., . . . Paschke, A. (2020). Evaluation of renal safety between Imipenem/Relebactam and Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections in the randomized, phase 3 RESTORE-IMI 1 study. Open Forum Infectious Diseases, 7(3), . https://doi.org/10.1093/ofid/ofaa054

Chicago Style (17th ed.) Citation

Brown, Michelle L., et al. "Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients with Imipenem-nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study." Open Forum Infectious Diseases 7, no. 3 (2020). https://doi.org/10.1093/ofid/ofaa054.

MLA (9th ed.) Citation

Brown, Michelle L., et al. "Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients with Imipenem-nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study." Open Forum Infectious Diseases, vol. 7, no. 3, 2020, https://doi.org/10.1093/ofid/ofaa054.